A retrospective analysis of proceduralist-directed, nurse-administered propofol sedation for implantable cardioverter-defibrillator procedures
- PMID: 22001710
- DOI: 10.1016/j.hrthm.2011.10.009
A retrospective analysis of proceduralist-directed, nurse-administered propofol sedation for implantable cardioverter-defibrillator procedures
Abstract
Background: There is controversy whether proceduralist-directed, nurse-administered propofol sedation (PDNAPS) is safe.
Objective: To assess the frequency of adverse events when PDNAPS is used for implantable cardioverter-defibrillator (ICD)-related procedures and to determine the patient and procedural characteristics associated with adverse events.
Methods: Consecutive ICD-related procedures using PDNAPS from May 2006 to July 2009 at a tertiary-care hospital were evaluated. Serious adverse events were defined as procedural death, unexpected transfer to an intensive care unit, respiratory failure requiring intubation/bag-mask ventilation, or hypotension requiring vasoconstrictor/inotrope support. Nonserious adverse events were defined as hypotension requiring fluid resuscitation or hypoxemia requiring augmented respiratory support with non-rebreather mask, oral airway, or jaw lift.
Results: Of 582 patients (age 64 ± 14 years, 72.3% males) undergoing ICD-related procedures using PDNAPS, 58 (10.0%) patients had serious adverse events with no procedural death and 225 (38.7%) had nonserious adverse events. Longer procedure duration (relative risk [RR] = 2.1 per hour; 95% confidence interval [CI] = 1.6-2.8; P < .001) and biventricular implant (RR = 2.7; CI = 1.4-5.3; P = .003) were independent predictors of serious adverse events. A longer procedure duration (RR = 1.4 per hour; CI = 1.1-1.7; P = .001), heart failure class (RR = 1.4 per 1 class; CI = 1.1-1.7; P = .002), and use of propofol infusion (RR = 3.5; CI = 2.2-5.7; P < .001) were independent predictors of nonserious adverse events.
Conclusion: PDNAPS for shorter ICD procedures including single- and dual-chamber implants, generator changes, and defibrillation threshold testing have acceptable rates of serious adverse events and manageable nonserious adverse events and should be considered for further study. Biventricular implants and other complex procedures should be done with an anesthesiologist.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Comment in
-
What is the best anesthetic for ICD implants?Heart Rhythm. 2012 Mar;9(3):349-50. doi: 10.1016/j.hrthm.2011.11.011. Epub 2011 Nov 11. Heart Rhythm. 2012. PMID: 22080110 No abstract available.
-
Components of safe propofol sedation: defining the formula.Heart Rhythm. 2012 Mar;9(3):347-8. doi: 10.1016/j.hrthm.2011.11.012. Epub 2011 Nov 11. Heart Rhythm. 2012. PMID: 22080111 No abstract available.
Similar articles
-
Monitored Anesthesia Care for Subcutaneous Cardioverter-Defibrillator Implantation: A Single-Center Experience.J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1228-33. doi: 10.1053/j.jvca.2016.06.007. Epub 2016 Jun 8. J Cardiothorac Vasc Anesth. 2016. PMID: 27640893
-
Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.J Clin Anesth. 2016 Jun;31:53-9. doi: 10.1016/j.jclinane.2015.11.009. Epub 2016 Mar 22. J Clin Anesth. 2016. PMID: 27185678 Clinical Trial.
-
Incidence of sedation-related complications with propofol use during advanced endoscopic procedures.Clin Gastroenterol Hepatol. 2010 Feb;8(2):137-42. doi: 10.1016/j.cgh.2009.07.008. Epub 2009 Jul 14. Clin Gastroenterol Hepatol. 2010. PMID: 19607937
-
Conscious sedation and implantable devices. Safe and effective sedation during pacemaker and implantable cardioverter defibrillator placement.Crit Care Nurs Clin North Am. 1997 Sep;9(3):325-34. Crit Care Nurs Clin North Am. 1997. PMID: 9355357 Review.
-
Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physicians.Pacing Clin Electrophysiol. 2018 Jul;41(7):807-816. doi: 10.1111/pace.13364. Epub 2018 Jun 8. Pacing Clin Electrophysiol. 2018. PMID: 29754394
Cited by
-
Heart Rythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety.Heart Rhythm. 2014 Aug;11(8):e9-51. doi: 10.1016/j.hrthm.2014.03.042. Epub 2014 May 7. Heart Rhythm. 2014. PMID: 24814989 Free PMC article. Review. No abstract available.
-
Effects of propofol sedation on pacing thresholds : Results from an observational cohort study.Herzschrittmacherther Elektrophysiol. 2018 Mar;29(1):127-132. doi: 10.1007/s00399-017-0538-7. Epub 2017 Nov 14. Herzschrittmacherther Elektrophysiol. 2018. PMID: 29138937 English.
-
Sedation in the Electrophysiology Laboratory: A Multidisciplinary Review.J Am Heart Assoc. 2016 Jun 13;5(6):e003629. doi: 10.1161/JAHA.116.003629. J Am Heart Assoc. 2016. PMID: 27412904 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical